Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seliger

Showing results (1-10 of 977) with videos related to

Pageof 98
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|January 6, 2006
Strategies of tumor immune evasionBarbara Seliger
Current Cardiology Reports|August 10, 2020
The Cardiorenal Syndrome: Mechanistic Insights and Prognostication with Soluble BiomarkersStephen Seliger
Journal of Clinical Medicine|December 11, 2019
Basis of PD1/PD-L1 TherapiesBarbara Seliger
Clinical Transplants|August 7, 2014
The non-classical antigens of HLA-G and HLA-E as diagnostic and prognostic biomarkers and as therapeutic targets in transplantation and tumorsBarbara Seliger
Cytokine & Growth Factor Reviews|July 26, 2017
Immune modulatory microRNAs as a novel mechanism to revert immune escape of tumorsBarbara Seliger
Human Immunology|May 5, 2016
Role of microRNAs on HLA-G expression in human tumorsBarbara Seliger
Current Protocols in Nucleic Acid Chemistry|April 23, 2008
Protection of 5'-hydroxy functions of nucleosidesH Seliger
Cancer Immunology, Immunotherapy : CII|June 22, 2023
Tumor immunology meets oncology (TIMO) XVI, July 07-09 2022 in Halle/Saale, GermanyBarbara Seliger
Cancer Immunology, Immunotherapy : CII|October 23, 2023
Tumor immunology meets oncology (TIMO) XVII, April 20-22 2023 in Halle/Saale, GermanyBarbara Seliger
Methods in Molecular Biology (Clifton, N.J.)|November 22, 2013
B7-H abnormalities in melanoma and clinical relevanceBarbara Seliger
Pageof 98

Showing results (1-10 of 977) with videos related to

Sort By:
Pageof 98
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|January 6, 2006
Strategies of tumor immune evasionBarbara Seliger
Current Cardiology Reports|August 10, 2020
The Cardiorenal Syndrome: Mechanistic Insights and Prognostication with Soluble BiomarkersStephen Seliger
Journal of Clinical Medicine|December 11, 2019
Basis of PD1/PD-L1 TherapiesBarbara Seliger
Clinical Transplants|August 7, 2014
The non-classical antigens of HLA-G and HLA-E as diagnostic and prognostic biomarkers and as therapeutic targets in transplantation and tumorsBarbara Seliger
Cytokine & Growth Factor Reviews|July 26, 2017
Immune modulatory microRNAs as a novel mechanism to revert immune escape of tumorsBarbara Seliger
Human Immunology|May 5, 2016
Role of microRNAs on HLA-G expression in human tumorsBarbara Seliger
Current Protocols in Nucleic Acid Chemistry|April 23, 2008
Protection of 5'-hydroxy functions of nucleosidesH Seliger
Cancer Immunology, Immunotherapy : CII|June 22, 2023
Tumor immunology meets oncology (TIMO) XVI, July 07-09 2022 in Halle/Saale, GermanyBarbara Seliger
Cancer Immunology, Immunotherapy : CII|October 23, 2023
Tumor immunology meets oncology (TIMO) XVII, April 20-22 2023 in Halle/Saale, GermanyBarbara Seliger
Methods in Molecular Biology (Clifton, N.J.)|November 22, 2013
B7-H abnormalities in melanoma and clinical relevanceBarbara Seliger
Pageof 98